BioCentury
ARTICLE | Clinical News

Ulimorelin: Completed Phase III enrollment

March 5, 2012 8:00 AM UTC

Tranzyme and Norgine completed enrollment of about 330 patients who have undergone partial bowel resection in the double-blind, placebo-controlled, international Phase III ULISES 008 trial evaluating ...